Progression of clinical and eye movement markers in preataxic carriers of Machado-Joseph Disease
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/256722 |
Resumo: | Background: Little is known about preclinical stages of Machado-Joseph disease, a polyglutamine disorder characterized by progressive adult-onset ataxia. Objective: We aimed to describe the longitudinal progression of clinical and oculomotor variables in the preataxic phase of disease. Methods: Carriers and noncarriers were assessed at three visits. Preataxic carriers (Scale for Assessment and Rating of Ataxia score < 3) expected to start ataxia in ≤4 years were considered near onset (PAN). Progressions of ataxic and preataxic carriers, considering status at the end of the study, were described according to the start (or its prediction) of gait ataxia (TimeToAfterOnset) and according to the study time. Results: A total of 35 ataxics, 38 preataxics, and 22 noncarriers were included. The “TimeToAfterOnset” timeline showed that Neurological Examination Scale for Spinocerebellar Ataxias (NESSCA; effect size, 0.09), Inventory of Non-Ataxia Symptoms (INAS0.07), and the vestibulo-ocular reflex gain (0.12) progressed in preataxic carriers, and that most slopes accelerate in PAN, turning similar to those of ataxics. In the study time, NESSCA (1.36) and vertical pursuit gain (1.17) significantly worsened in PAN, and 6 of 11 PANs converted to ataxia. For a clinical trial with 80% power and 2-year duration, 57 PANs are needed in each study arm to detect a 50% reduction in the conversion rate. Conclusions: NESSCA, INAS, vestibulo-ocular reflex, and vertical pursuit gains significantly worsened in the preataxic phase. The “TimeToAfterOnset” timeline unveiled that slopes of most variables are small in preataxics but increase and reach the ataxic slopes from 4 years before the onset of ataxia. For future trials in preataxic carriers, we recommend recruiting PANs and using the conversion rate as the primary outcome. © 2022 International Parkinson and Movement Disorder Society. |
id |
UFRGS-2_e570acbe3b1e178412c4fd340dc57260 |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/256722 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Oliveira, Camila Maria deLeotti, Vanessa BielefeldtCappelli, Amanda HenzRocha, Anastácia GuimarãesEcco, GabrielaBolzan, GabrielaKersting, NatháliaPereira, Maria Luiza SaraivaJardim, Laura Bannach2023-04-05T03:47:53Z20231531-8257http://hdl.handle.net/10183/256722001165535Background: Little is known about preclinical stages of Machado-Joseph disease, a polyglutamine disorder characterized by progressive adult-onset ataxia. Objective: We aimed to describe the longitudinal progression of clinical and oculomotor variables in the preataxic phase of disease. Methods: Carriers and noncarriers were assessed at three visits. Preataxic carriers (Scale for Assessment and Rating of Ataxia score < 3) expected to start ataxia in ≤4 years were considered near onset (PAN). Progressions of ataxic and preataxic carriers, considering status at the end of the study, were described according to the start (or its prediction) of gait ataxia (TimeToAfterOnset) and according to the study time. Results: A total of 35 ataxics, 38 preataxics, and 22 noncarriers were included. The “TimeToAfterOnset” timeline showed that Neurological Examination Scale for Spinocerebellar Ataxias (NESSCA; effect size, 0.09), Inventory of Non-Ataxia Symptoms (INAS0.07), and the vestibulo-ocular reflex gain (0.12) progressed in preataxic carriers, and that most slopes accelerate in PAN, turning similar to those of ataxics. In the study time, NESSCA (1.36) and vertical pursuit gain (1.17) significantly worsened in PAN, and 6 of 11 PANs converted to ataxia. For a clinical trial with 80% power and 2-year duration, 57 PANs are needed in each study arm to detect a 50% reduction in the conversion rate. Conclusions: NESSCA, INAS, vestibulo-ocular reflex, and vertical pursuit gains significantly worsened in the preataxic phase. The “TimeToAfterOnset” timeline unveiled that slopes of most variables are small in preataxics but increase and reach the ataxic slopes from 4 years before the onset of ataxia. For future trials in preataxic carriers, we recommend recruiting PANs and using the conversion rate as the primary outcome. © 2022 International Parkinson and Movement Disorder Society.application/pdfengMovement disorders. New York. Vol. 38, no. 1 (Jan. 2023), p. 26-34Doença de Machado-JosephBiomarcadoresMovimentos ocularesProgressão da doençaSpinocerebellar ataxia type 3BiomarkersPre-ataxic periodProgression of clinical and eye movement markers in preataxic carriers of Machado-Joseph DiseaseEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001165535.pdf.txt001165535.pdf.txtExtracted Texttext/plain45958http://www.lume.ufrgs.br/bitstream/10183/256722/2/001165535.pdf.txtf8516bcb1efe96afe5fc0e15116b0b6fMD52ORIGINAL001165535.pdfTexto completo (inglês)application/pdf1120543http://www.lume.ufrgs.br/bitstream/10183/256722/1/001165535.pdffc099f90c460c5f96e81b3b815e065cfMD5110183/2567222023-07-28 03:34:55.842768oai:www.lume.ufrgs.br:10183/256722Repositório InstitucionalPUBhttps://lume.ufrgs.br/oai/requestlume@ufrgs.bropendoar:2023-07-28T06:34:55Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Progression of clinical and eye movement markers in preataxic carriers of Machado-Joseph Disease |
title |
Progression of clinical and eye movement markers in preataxic carriers of Machado-Joseph Disease |
spellingShingle |
Progression of clinical and eye movement markers in preataxic carriers of Machado-Joseph Disease Oliveira, Camila Maria de Doença de Machado-Joseph Biomarcadores Movimentos oculares Progressão da doença Spinocerebellar ataxia type 3 Biomarkers Pre-ataxic period |
title_short |
Progression of clinical and eye movement markers in preataxic carriers of Machado-Joseph Disease |
title_full |
Progression of clinical and eye movement markers in preataxic carriers of Machado-Joseph Disease |
title_fullStr |
Progression of clinical and eye movement markers in preataxic carriers of Machado-Joseph Disease |
title_full_unstemmed |
Progression of clinical and eye movement markers in preataxic carriers of Machado-Joseph Disease |
title_sort |
Progression of clinical and eye movement markers in preataxic carriers of Machado-Joseph Disease |
author |
Oliveira, Camila Maria de |
author_facet |
Oliveira, Camila Maria de Leotti, Vanessa Bielefeldt Cappelli, Amanda Henz Rocha, Anastácia Guimarães Ecco, Gabriela Bolzan, Gabriela Kersting, Nathália Pereira, Maria Luiza Saraiva Jardim, Laura Bannach |
author_role |
author |
author2 |
Leotti, Vanessa Bielefeldt Cappelli, Amanda Henz Rocha, Anastácia Guimarães Ecco, Gabriela Bolzan, Gabriela Kersting, Nathália Pereira, Maria Luiza Saraiva Jardim, Laura Bannach |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Oliveira, Camila Maria de Leotti, Vanessa Bielefeldt Cappelli, Amanda Henz Rocha, Anastácia Guimarães Ecco, Gabriela Bolzan, Gabriela Kersting, Nathália Pereira, Maria Luiza Saraiva Jardim, Laura Bannach |
dc.subject.por.fl_str_mv |
Doença de Machado-Joseph Biomarcadores Movimentos oculares Progressão da doença |
topic |
Doença de Machado-Joseph Biomarcadores Movimentos oculares Progressão da doença Spinocerebellar ataxia type 3 Biomarkers Pre-ataxic period |
dc.subject.eng.fl_str_mv |
Spinocerebellar ataxia type 3 Biomarkers Pre-ataxic period |
description |
Background: Little is known about preclinical stages of Machado-Joseph disease, a polyglutamine disorder characterized by progressive adult-onset ataxia. Objective: We aimed to describe the longitudinal progression of clinical and oculomotor variables in the preataxic phase of disease. Methods: Carriers and noncarriers were assessed at three visits. Preataxic carriers (Scale for Assessment and Rating of Ataxia score < 3) expected to start ataxia in ≤4 years were considered near onset (PAN). Progressions of ataxic and preataxic carriers, considering status at the end of the study, were described according to the start (or its prediction) of gait ataxia (TimeToAfterOnset) and according to the study time. Results: A total of 35 ataxics, 38 preataxics, and 22 noncarriers were included. The “TimeToAfterOnset” timeline showed that Neurological Examination Scale for Spinocerebellar Ataxias (NESSCA; effect size, 0.09), Inventory of Non-Ataxia Symptoms (INAS0.07), and the vestibulo-ocular reflex gain (0.12) progressed in preataxic carriers, and that most slopes accelerate in PAN, turning similar to those of ataxics. In the study time, NESSCA (1.36) and vertical pursuit gain (1.17) significantly worsened in PAN, and 6 of 11 PANs converted to ataxia. For a clinical trial with 80% power and 2-year duration, 57 PANs are needed in each study arm to detect a 50% reduction in the conversion rate. Conclusions: NESSCA, INAS, vestibulo-ocular reflex, and vertical pursuit gains significantly worsened in the preataxic phase. The “TimeToAfterOnset” timeline unveiled that slopes of most variables are small in preataxics but increase and reach the ataxic slopes from 4 years before the onset of ataxia. For future trials in preataxic carriers, we recommend recruiting PANs and using the conversion rate as the primary outcome. © 2022 International Parkinson and Movement Disorder Society. |
publishDate |
2023 |
dc.date.accessioned.fl_str_mv |
2023-04-05T03:47:53Z |
dc.date.issued.fl_str_mv |
2023 |
dc.type.driver.fl_str_mv |
Estrangeiro info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/256722 |
dc.identifier.issn.pt_BR.fl_str_mv |
1531-8257 |
dc.identifier.nrb.pt_BR.fl_str_mv |
001165535 |
identifier_str_mv |
1531-8257 001165535 |
url |
http://hdl.handle.net/10183/256722 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Movement disorders. New York. Vol. 38, no. 1 (Jan. 2023), p. 26-34 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/256722/2/001165535.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/256722/1/001165535.pdf |
bitstream.checksum.fl_str_mv |
f8516bcb1efe96afe5fc0e15116b0b6f fc099f90c460c5f96e81b3b815e065cf |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
lume@ufrgs.br |
_version_ |
1817725160696840192 |